¼¼°èÀÇ ¿©¼º °Ç°­ ¾Û ½ÃÀå
»óǰÄÚµå : 1784853
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 293 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,150,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,452,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¿©¼º °Ç°­ ¾Û ½ÃÀåÀº 2030³â±îÁö 122¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 47¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿©¼º °Ç°­ ¾Û ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 17.2%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 122¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÇÇÆ®´Ï½º ¹× ¿µ¾çÀº CAGR 19.6%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 41¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿ù°æ °Ç°­ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ CAGR·Î 14.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 13¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR23.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿©¼º °Ç°­ ¾Û ½ÃÀåÀº 2024³â¿¡ 13¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 27¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 23.0%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 12.5%¿Í 15.6%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 13.7%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¿©¼º °Ç°­ ¾Û ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿©¼º °Ç°­ ¾ÛÀÌ °³ÀÎ ¸ÂÃãÇü °Ç°­ °ü¸®¸¦ ÀçÁ¤ÀÇÇÒ °ÍÀΰ¡? ±× ¿µÇâ·Â ½ÉÃþ ºÐ¼®

¿©¼ºµéÀÇ °Ç°­ ´ÏÁî¿¡ ƯȭµÈ µðÁöÅÐ °Ç°­ ¾ÛÀÇ µîÀåÀ¸·Î ¿©¼º °Ç°­°ü¸®ÀÇ »óȲÀº ÆÐ·¯´ÙÀÓÀÇ ÀüȯÀ» ¸ÂÀÌÇϰí ÀÖ½À´Ï´Ù. ¿©¼º °Ç°­ ¾ÛÀº °íµµ·Î °³ÀÎÈ­µÈ °ü¸®¸¦ Á¦°øÇϵµ·Ï ¼³°èµÇ¾î »ý½Ä °Ç°­, ºÒÀÓ ÃßÀû, Àӽаü¸®, °»³â±â Áö¿ø, ¸¸¼º Áúȯ ¿¹¹æ¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÀÚ°¡ ¸ð´ÏÅ͸µ°ú Àû±ØÀûÀÎ °Ç°­ °ü¸®ÀÇ Á߿伺ÀÌ ÀνĵǸ鼭, ÀÌ·¯ÇÑ ¾ÛÀº ¼ö¹é¸¸ ¸íÀÇ ¿©¼ºµé¿¡°Ô ÀÚ½ÅÀÇ °Ç°­À» ÅëÁ¦ÇÒ ¼ö ÀÖ´Â ±ÇÇÑÀ» ºÎ¿©Çϰí ÀÖ½À´Ï´Ù. ½Ã°£À̳ª Á¢±Ù¼ºÀÌ Á¦ÇÑÀûÀÎ ±âÁ¸ Áø·á¿Í´Â ´Þ¸®, °Ç°­ ¾ÛÀº ½Ç½Ã°£ ÃßÀû, µ¥ÀÌÅÍ ºÐ¼®, AI ±â¹Ý ÀλçÀÌÆ®¸¦ Á¦°øÇÏ¿© »ç¿ëÀÚ°¡ ÀÚ½ÅÀÇ °Ç°­¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. »ý¸®ÁÖ±â ÃßÀû, ¹è¶õÀÏ °¨Áö, Àӽаæ°ú ¸ð´ÏÅ͸µ, È£¸£¸ó ºÒ±ÕÇü °ü·Ã Áõ»ó ¿¹Ãø±îÁö °¡´ÉÇØÁö¸é¼­ ¿©¼º ½º½º·ÎÀÇ °Ç°­ °ü¸® ´É·ÂÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ¿þ¾î·¯ºí ±â±â¸¦ ÀÌ·¯ÇÑ ¾Û°ú ÅëÇÕÇÏ¿© ½É¹Ú¼ö, ¼ö¸é ÁÖ±â, ½ºÆ®·¹½º ¼öÁذú °°Àº Áß¿äÇÑ ¸Å°³ º¯¼ö¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ¿© ¿©¼ºÀÇ °Ç°­ »óŸ¦ Àü¹ÝÀûÀ¸·Î ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »êÈÄ ¿ì¿ïÁõ, ºÒ¾È, ½ºÆ®·¹½º °ü¸®¿Í °ü·ÃµÈ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ ÀÌ·¯ÇÑ ¿ëµµÀÇ Á¤½Å °Ç°­ ±â´ÉÀÌ Á¡Á¡ ´õ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. »ç¿ëÀÚ Ä£È­ÀûÀÌ°í µ¥ÀÌÅÍ ±â¹Ý ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó, ¿©¼º °Ç°­ ¾ÛÀº °³ÀÎÀÇ ÀÇ·á °æÇèÀ» º¯È­½Ãų »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü °£ÀÇ °ÝÂ÷¸¦ ÇØ¼ÒÇÔÀ¸·Î½á º¸´Ù ±¤¹üÀ§ÇÑ ÀÇ·á »ýŰ踦 À籸¼ºÇϰí ÀÖ½À´Ï´Ù.

ÆèÅ×Å©´Â ¿Ö ¹Ì·¡Àΰ¡? µðÁöÅÐ ¿©¼º °Ç°­ ¼Ö·ç¼ÇÀÇ ±Þ°ÝÇÑ Áõ°¡¿¡ ´ëÇØ ¾Ë¾Æº¾´Ï´Ù.

±â¼ú ÁÖµµÀÇ ¿©¼º °Ç°­ °ü¸®¿¡ ƯȭµÇ¾î ±Þ¼ºÀåÇϰí ÀÖ´Â ºÐ¾ßÀÎ ÆèÅ×Å©´Â ¿©¼º °Ç°­ ¾ÛÀÇ º¸±Þ¿¡ Å« °è±â¸¦ ¸¶·ÃÇß½À´Ï´Ù. ÀÌ·¯ÇÑ °ü½É Áõ°¡´Â ÀüÅëÀûÀÎ ÀÇÇÐ ¿¬±¸¿¡¼­ ¿©¼º »ý¸®ÇÐÀÇ Áß¿äÇÑ Ãø¸éÀÌ °£°úµÇ±â ½¬¿î ¼ºº°¿¡ ƯȭµÈ °Ç°­ °ü¸® ¼Ö·ç¼ÇÀÇ ¿À·£ °ÝÂ÷¿¡¼­ ±âÀÎÇÕ´Ï´Ù. ¿©¼º Àü¿ë °Ç°­ ¾ÛÀº ÀÌ·¯ÇÑ °ÝÂ÷¸¦ ÇØ¼ÒÇÏ°í ´Ù³¶¼º³­¼ÒÁõÈıº(PCOS), Àڱ󻸷Áõ, °»³â±â Áõ»ó µî ±×µ¿¾È Á¦´ë·Î Áø´ÜµÇÁö ¾Ê¾Ò°Å³ª Á¦´ë·Î °ü¸®µÇÁö ¾Ê¾Ò´ø ¹®Á¦µé¿¡ ´ëÇÑ ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. AI ±â¹Ý »ý½Ä ÀÇ·á ÃßÀû µµ±¸ÀÇ µîÀåÀ¸·Î º¸´Ù Á¤È®ÇÑ ¹è¶õ ¿¹Ãø, ´õ ³ªÀº Àӽаèȹ, ÇÇÀÓ ¸ð´ÏÅ͸µ °­È­°¡ °¡´ÉÇØÁö¸é¼­ °¡Á· °èȹÀÇ ¼±Åÿ¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ¸¸, ´ç´¢º´, ½ÉÇ÷°ü Áúȯ µî »ýȰ½À°üº´ÀÌ Á¡Á¡ ´õ ³Î¸® ÆÛÁö°í ÀÖ°í, ±× Áß »ó´ç¼ö°¡ ¿©¼º¿¡°Ô ºÒ±ÕÇüÀûÀ¸·Î ¿µÇâÀ» ¹ÌÄ¡°í Àֱ⠶§¹®¿¡ µðÁöÅÐ °Ç°­ ¿ëµµ´Â ¿¹¹æÀû °Ç°­°ü¸®¸¦ ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ±â¾÷Àº °í±Þ ºÐ¼®, ¸Ó½Å·¯´× ¾Ë°í¸®Áò, µðÁöÅÐ ¹ÙÀÌ¿À¸¶Ä¿¸¦ ÅëÇÕÇÏ¿© °³ÀÎÀÇ °Ç°­ ÆÐÅÏ¿¡ µû¶ó ¸ÂÃãÇü ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ¶Ç ´Ù¸¥ ÁÖ¿ä ¹ßÀüÀº ¿ø°Ý Áø·á¿Í °¡»ó °Ç°­ °ü¸®·ÎÀÇ ÀüȯÀ¸·Î, ¿©¼ºµéÀº ¹°¸®Àû ¹æ¹®ÀÇ Á¦¾à ¾øÀÌ Àü¹®°¡ÀÇ ÀÇ·á Á¶¾ðÀ» ¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ´õ ¸¹Àº ÀÇ·á Àü¹®°¡µéÀÌ ÀÌ·¯ÇÑ ¾ÛÀ» ÀÓ»ó¿¡ µµÀÔÇÔ¿¡ µû¶ó µðÁöÅÐ °Ç°­ ¼Ö·ç¼ÇÀÇ ½Å·Ú¼º°ú ½Å·Ú¼ºÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Á¤ºÎ ¹× ±ÔÁ¦ ±â°üÀÌ ÆèÅ×Å© Çõ½ÅÀÇ Á߿伺À» ÀÎÁ¤Çϱ⠽ÃÀÛÇϸ鼭 Á¤Ã¥Àû Â÷¿øÀÇ Áö¿øÀÌ ÀÌ ºÐ¾ß¸¦ ´õ¿í ¹ßÀü½Ã۰í ÀÖ½À´Ï´Ù. µðÁöÅÐ °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿©¼ºÀÇ ÀÇÁö°¡ ³ô¾ÆÁø °ÍÀº ±â¼úÀÌ ´õ ÀÌ»ó º¸Á¶ÀûÀÎ µµ±¸°¡ ¾Æ´Ï¶ó ÀÇ·á Á¢±Ù¼º°ú È¿À²¼ºÀ» ³ôÀÌ´Â ÁÖ¿ä µ¿·ÂÀ¸·Î °£ÁֵǴ º¸´Ù ±¤¹üÀ§ÇÑ ¹®È­Àû º¯È­¸¦ º¸¿©ÁÝ´Ï´Ù.

AI´Â ¿©¼º °Ç°­ ¾Û¿¡ ¾î¶² Çõ¸íÀ» °¡Á®¿Ã±î? ½º¸¶Æ® & ¿¹Ãø ÀÇ·áÀÇ ºÎ»ó

ÀΰøÁö´É(AI)Àº ¿¹Ãø ºÐ¼®, Á¶±â Áø´Ü, °íµµ·Î °³ÀÎÈ­µÈ Ä¡·á¹ý ÃßõÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ¿©¼º °Ç°­ ¿ëµµÀÇ Çõ½ÅÀÇ ÃÖÀü¼±¿¡ ¼­ ÀÖ½À´Ï´Ù. AI¸¦ Ȱ¿ëÇÑ »ý¸® ¹× ºÒÀÓ ÃßÀû ¾ÛÀº ÇöÀç È£¸£¸ó ºÒ±ÕÇü, °©»ó¼± Àå¾Ö, »ý½Ä °ü·Ã °Ç°­ ¹®Á¦ µî ±Ùº»ÀûÀÎ °Ç°­ »óŸ¦ ³ªÅ¸³¾ ¼ö ÀÖ´Â ºÒ±ÔÄ¢¼ºÀ» °¨ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. »ç¿ëÀڷκÎÅÍ ¼öÁýÇÑ ¹æ´ëÇÑ µ¥ÀÌÅÍ ¼¼Æ®¸¦ ºÐ¼®ÇÏ¿© AI ¾Ë°í¸®ÁòÀÌ ÆÐÅÏÀ» ÀνÄÇÏ°í »çÀü ¿¹¹æÀû ÃßõÀ» Á¦°øÇÔÀ¸·Î½á °Ç°­ À§ÇèÀÌ È®´ëµÇ±â Àü¿¡ ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿¹Ãø ´É·ÂÀº Á¤È®ÇÑ Å¸À̹ÖÀÌ Àӽмº°ø·ü¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ºÒÀÓ Ä¡·á¿¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. AI ±â¹Ý 꺿°ú °¡»ó ºñ¼­´Â 24½Ã°£ 365ÀÏ ¾È³», °Ç°­ °ü·Ã ¹®ÀÇ¿¡ ´ëÇÑ ´äº¯, »êÈÄ¿ì¿ïÁõÀ̳ª °»³â±â ºÒ¾È°ú °°Àº Áõ»ó¿¡ ´ëÇÑ Á¤½ÅÀû Áö¿øÀ» Á¦°øÇÔÀ¸·Î½á »ç¿ëÀÚ °æÇè¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. AI¸¦ Ȱ¿ëÇÑ ¿©¼º °Ç°­ ¾ÛÀÇ ¶Ç ´Ù¸¥ Çõ½ÅÀº À¯ÀüüÇÐ ¹× Á¤¹ÐÀÇ·á¿ÍÀÇ ÅëÇÕÀ» ÅëÇØ °íµµ·Î °³ÀÎÈ­µÈ ÇコÄÉ¾î ¼Ö·ç¼ÇÀ» °¡´ÉÇÏ°Ô ÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¿ëµµ´Â ÇöÀç À¯ÀüÀÚ ¸¶Ä¿¸¦ ÅëÇÕÇÏ¿© ºÒÀÓ ¿¹ÃøÀ» Á¤±³È­Çϰí, »ýȰ½À°ü º¯È­¸¦ ±ÇÀåÇϸç, ¸¸¼ºÁúȯÀÇ Ä¡·á °èȹÀ» ÃÖÀûÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ AI´Â ºñħ½ÀÀû Áø´ÜÀÇ Á¤È®µµ¸¦ ³ôÀ̰í ÀÖÀ¸¸ç, ƯÈ÷ ½º¸¶Æ®Æù ±â¹Ý ¿µ»ó ±â¼úÀ» ÅëÇÑ À¯¹æ¾Ï À§Çè ¹× ÀڱðæºÎ ÀÌ»ó È®Àο¡ Å« À§·ÂÀ» ¹ßÈÖÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °Ç°­ ¾Û¿¡ ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀ» Á¢¸ñÇÏ¿© ¾Ë¸²À» Á¦°øÇÏ°í ºÎÀÛ¿ëÀ» ÃßÀûÇÔÀ¸·Î½á º¹¾à ¼øÀÀµµ¸¦ Çâ»ó½Ã۰í, »ç¿ëÀÚ°¡ ó¹æµÈ ¾à¹°À» Áö¼ÓÀûÀ¸·Î º¹¿ëÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. AI°¡ °è¼Ó ÁøÈ­ÇÔ¿¡ µû¶ó ¿©¼º °Ç°­ ¾ÛÀÇ ¹Ì·¡´Â ±âº»ÀûÀÎ ÃßÀû µµ±¸¿¡¼­ Àü·Ê ¾ø´Â Á¤È®µµ·Î °³ÀÎÈ­µÈ ÅëÂû·ÂÀ» Á¦°øÇÒ ¼ö ÀÖ´Â Áö´ÉÇü µ¥ÀÌÅÍ ±â¹Ý ÇコÄÉ¾î »ýŰè·Î ÀüȯµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀÌ ¼º¼÷ÇØÁü¿¡ µû¶ó ÁÖ·ù ÀÇ·áÀÇ ÇʼöÀûÀÎ ºÎºÐÀÌ µÇ¾î ¿©¼º¿¡°Ô º¸´Ù ½º¸¶Æ®ÇÏ°í ´Éµ¿ÀûÀÎ °Ç°­ °ü¸® ¼Ö·ç¼ÇÀ» Á¦°øÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

¿©¼º °Ç°­ ¾ÛÀÇ ±Þ°ÝÇÑ ¼ºÀåÀ» À̲ô´Â ¿äÀÎÀº ¹«¾ùÀΰ¡? ½ÃÀå ¼ºÀå ÃËÁø¿äÀο¡ ´ëÇÑ ÀÌÇØ

¿©¼º °Ç°­ ¾Û ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ¼ÒºñÀÚ Çൿ º¯È­, ÆèÅ×Å© Çõ½Å¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ½º¸¶Æ®Æù ¹× ¿þ¾î·¯ºí ±â±âÀÇ º¸±ÞÀ¸·Î µðÁöÅÐ °Ç°­ ¼Ö·ç¼ÇÀÌ Àü ¼¼°è ¿©¼ºµé¿¡°Ô ´õ¿í Ä£¼÷ÇØÁ³±â ¶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ÀÚ°¡ °ü¸® ¹× ¿¹¹æÀû °Ç°­°ü¸®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ Å« ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖÀ¸¸ç, Á¡Á¡ ´õ ¸¹Àº ¿©¼ºµéÀÌ »ý½Ä ¹× Àü¹ÝÀûÀÎ °Ç°­ °ü¸®¸¦ À§ÇØ Àû±ØÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Ãß±¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ¾ÛÀÌ ¿ø°Ý ÀÇ·á Ç÷§Æû°ú ÅëÇյǸ鼭 ƯÈ÷ ÀüÅëÀûÀÎ ÀÇ·á ¼­ºñ½º Á¢±Ù¼ºÀÌ Á¦ÇÑÀûÀÎ Áö¿ª¿¡¼­ µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ÆèÅØ ½ºÅ¸Æ®¾÷¿¡ ´ëÇÑ º¥Ã³Ä³ÇÇÅÐÀÇ ÀÚ±Ý Áö¿øÀÌ ±ÞÁõÇÏ´Â °Íµµ °íµµ·Î Á¤±³ÇÏ°í ±â´ÉÀÌ Ç³ºÎÇÑ ¾ÖÇø®ÄÉÀÌ¼Ç °³¹ßÀ» °¡´ÉÇÏ°Ô ÇÏ´Â Áß¿äÇÑ ÃËÁø¿äÀÎÀÔ´Ï´Ù. ±â¾÷µéÀº ÇöÀç ºòµ¥ÀÌÅÍ, Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ, ºí·ÏüÀÎ ±â¼úÀ» Ȱ¿ëÇÏ¿© µ¥ÀÌÅÍ º¸¾ÈÀ» °­È­Çϰí, »óÈ£ ¿î¿ë¼ºÀ» Çâ»ó½Ã۸ç, ÀÇ·á ±â·Ï¿¡ ´ëÇÑ ¿øÈ°ÇÑ ¾×¼¼½º¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ¿©¼º °Ç°­ °ü¸®¸¦ °³¼±Çϱâ À§ÇÑ ±ÔÁ¦ Áö¿ø°ú Á¤Ã¥Àû Â÷¿øÀÇ °³ÀÔÀÌ µðÁöÅÐ Çコ µµÀÔ¿¡ µµ¿òÀÌ µÇ´Â ȯ°æÀ» Á¶¼ºÇϰí ÀÖ½À´Ï´Ù. º¸Çè Á¦°ø¾÷ü¿Í ±â¾÷ À£´Ï½º ÇÁ·Î±×·¥µµ ¿©¼º °Ç°­ ¾ÛÀ» ÀÚ»ç Á¦Ç°¿¡ ÅëÇÕÇϱ⠽ÃÀÛÇßÀ¸¸ç, ÁÖ·ù·Î ¹Þ¾Æµé¿©Áö°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚÀÇ ÃëÇâÀÌ ÁøÈ­Çϸ鼭 ½ÅüÀû, Á¤½ÅÀû, »ý½ÄÀû °Ç°­À» °áÇÕÇÑ ÃÑüÀû °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. µðÁöÅÐ ÇÇÀÓ¾à, °³ÀÎ ¸ÂÃãÇü È£¸£¸ó ¿ä¹ý ÃßÀû, AI¸¦ Ȱ¿ëÇÑ Áø´ÜÀÇ È®´ë´Â ½ÃÀåÀÇ ÀáÀç·ÂÀ» ´õ¿í º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. Àå±âÀûÀÎ ÇコÄÉ¾î ¼Ö·ç¼ÇÀ» ÇÊ¿ä·Î ÇÏ´Â ¿©¼º Àα¸ÀÇ °í·ÉÈ­¿¡ µû¶ó °»³â±â °ü·Ã µðÁöÅÐ °Ç°­ °³ÀÔ¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼ºº°¿¡ ƯȭµÈ ÇコÄɾ ´ëÇÑ »çȸÀû ÀνÄÀÌ ³ô¾ÆÁö°í, µðÁöÅÐ ±â¼ú Çõ½ÅÀ¸·Î °³ÀÎÈ­µÈ Ä¡·á ¿É¼ÇÀÌ °è¼Ó Á¤±³ÇØÁö¸é¼­ ¿©¼º °Ç°­ ¾Û ½ÃÀåÀº ºñ¾àÀûÀ¸·Î ¼ºÀåÇϰí ÀÖÀ¸¸ç, ¿©¼º °Ç°­ °ü¸®ÀÇ ¹Ì·¡¸¦ ÀçÁ¤ÀÇÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

ºÎ¹®

À¯Çü(ÇÇÆ®´Ï½º ¹× ¿µ¾ç, ¿ù°æ °Ç°­, ÀӽŠÃßÀû ¹× »êÈÄ Äɾî, °»³â±â, Áúº´ °ü¸®, ±âŸ), ¸ð´Þ¸®Æ¼(½º¸¶Æ®Æù, ÅÂºí¸´, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Äõ¸® ÇÏ´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Women's Health Apps Market to Reach US$12.2 Billion by 2030

The global market for Women's Health Apps estimated at US$4.7 Billion in the year 2024, is expected to reach US$12.2 Billion by 2030, growing at a CAGR of 17.2% over the analysis period 2024-2030. Fitness & Nutrition, one of the segments analyzed in the report, is expected to record a 19.6% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Menstrual Health segment is estimated at 14.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 23.0% CAGR

The Women's Health Apps market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 23.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.5% and 15.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.7% CAGR.

Global Women’s Health App Market - Key Trends & Drivers Summarized

Are Women’s Health Apps Redefining Personalized Healthcare? A Deep Dive into Their Impact

The landscape of women's healthcare is undergoing a paradigm shift, driven by the rise of digital health applications tailored specifically for female health needs. Women’s health apps are designed to provide highly personalized care, offering insights into reproductive health, fertility tracking, pregnancy management, menopause support, and chronic disease prevention. With the growing awareness of the importance of self-monitoring and proactive healthcare, these apps have empowered millions of women to take control of their well-being. Unlike traditional medical consultations, which can often be limited by time and accessibility, health apps offer real-time tracking, data analysis, and AI-driven insights that help users make informed decisions about their health. The ability to track menstrual cycles, detect ovulation windows, monitor pregnancy progress, and even predict symptoms related to hormonal imbalances has significantly enhanced women’s ability to manage their own health. Moreover, the integration of wearable devices with these apps allows for continuous monitoring of vital parameters such as heart rate, sleep cycles, and stress levels, providing a holistic view of a woman's health profile. Additionally, the increasing popularity of mental wellness features in these applications is addressing concerns related to postpartum depression, anxiety, and stress management. With the growing demand for user-friendly and data-driven solutions, women’s health apps are not only transforming individual healthcare experiences but also reshaping the broader healthcare ecosystem by bridging the gap between patients and providers.

Why Is Femtech the Future? Exploring the Surge in Digital Women’s Health Solutions

Femtech, a rapidly expanding sector dedicated to technology-driven women’s healthcare, has been a major catalyst in the adoption of women’s health apps. The surge in interest can be attributed to a long-standing gap in gender-specific healthcare solutions, where traditional medical research often overlooked key aspects of female physiology. Health apps designed exclusively for women are addressing these gaps, offering tailored solutions for conditions such as polycystic ovary syndrome (PCOS), endometriosis, and perimenopausal symptoms-issues that have historically been underdiagnosed or inadequately managed. The rise of AI-powered reproductive health tracking tools is enabling more precise ovulation predictions, better fertility planning, and enhanced contraceptive monitoring, all of which are revolutionizing family planning options. Furthermore, with the increasing prevalence of lifestyle diseases such as obesity, diabetes, and cardiovascular disorders-many of which disproportionately affect women-digital health applications are playing a crucial role in promoting preventative healthcare. Companies are integrating advanced analytics, machine learning algorithms, and digital biomarkers to offer customized insights based on individual health patterns. Another key development is the shift toward remote consultations and virtual healthcare, allowing women to receive expert medical advice without the constraints of physical visits. As more healthcare professionals integrate these apps into their clinical practice, the credibility and reliability of digital health solutions are increasing. With governments and regulatory bodies beginning to acknowledge the importance of femtech innovations, policy-level support is further propelling the sector forward. The increasing willingness of women to engage with digital health solutions is indicative of a broader cultural shift, one where technology is no longer viewed as a supplementary tool but as a primary driver of healthcare accessibility and efficiency.

How Is AI Revolutionizing Women’s Health Apps? The Rise of Smart & Predictive Healthcare

Artificial intelligence (AI) is at the forefront of innovation in women’s health applications, enabling predictive analytics, early diagnosis, and highly personalized treatment recommendations. AI-driven menstrual and fertility tracking apps are now capable of detecting irregularities that could indicate underlying health conditions such as hormonal imbalances, thyroid disorders, or reproductive health concerns. By analyzing vast datasets collected from users, AI algorithms can recognize patterns and provide proactive recommendations, minimizing health risks before they escalate. This predictive capability is particularly useful for fertility treatments, where precision timing plays a critical role in conception success rates. AI-powered chatbots and virtual assistants are also revolutionizing user experience by providing 24/7 guidance, answering health-related queries, and offering emotional support for conditions such as postpartum depression and perimenopausal anxiety. Another breakthrough in AI-powered women’s health apps is their integration with genomics and precision medicine, allowing for highly individualized healthcare solutions. These applications can now incorporate genetic markers to refine fertility predictions, recommend lifestyle changes, and optimize treatment plans for chronic diseases. Additionally, AI is enhancing the accuracy of non-invasive diagnostics, particularly in identifying breast cancer risks and cervical abnormalities through smartphone-based imaging technology. The incorporation of machine learning algorithms into health apps is also improving medication adherence by providing reminders and tracking side effects, ensuring users stay on top of their prescribed regimens. With AI continuously evolving, the future of women’s health apps is shifting from basic tracking tools to intelligent, data-driven healthcare ecosystems capable of delivering personalized insights with an unprecedented level of accuracy. As this technology matures, it is expected to become an integral part of mainstream medical practice, providing women with smarter, more proactive healthcare solutions.

What’s Fueling the Rapid Growth of Women’s Health Apps? Unpacking the Market Drivers

The growth in the women’s health app market is driven by several factors, including technological advancements, shifting consumer behaviors, and increasing investment in femtech innovations. One of the primary drivers is the widespread adoption of smartphones and wearable devices, which has made digital health solutions more accessible to women worldwide. The growing demand for self-care and preventive healthcare is also a significant factor, as more women seek proactive approaches to managing their reproductive and general health. Furthermore, the integration of these apps with telemedicine platforms has accelerated adoption, particularly in regions with limited access to traditional healthcare services. The surge in venture capital funding for femtech startups is another crucial growth driver, enabling the development of highly sophisticated and feature-rich applications. Companies are now leveraging big data, cloud computing, and blockchain technology to enhance data security, improve interoperability, and provide seamless access to health records. Additionally, regulatory support and policy-level interventions aimed at improving women’s healthcare are fostering an environment conducive to digital health adoption. Insurance providers and corporate wellness programs are also beginning to integrate women’s health apps into their offerings, increasing their mainstream acceptance. Consumer preferences are evolving, with an increasing emphasis on holistic health solutions that combine physical, mental, and reproductive well-being. The expansion of digital contraceptives, personalized hormone therapy tracking, and AI-powered diagnostics further demonstrates the market’s potential. With an aging female population requiring long-term healthcare solutions, the demand for menopause-related digital health interventions is also rising. As societal awareness of gender-specific healthcare needs grows, and digital innovations continue to refine personalized treatment options, the women’s health app market is poised for exponential expansion, redefining the future of women’s healthcare.

SCOPE OF STUDY:

The report analyzes the Women's Health Apps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Fitness & Nutrition, Menstrual Health, Pregnancy Tracking & Postpartum Care, Menopause, Disease Management, Others); Modality (Smartphone, Tablet, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â